Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Short term Debt (2022 - 2023)

Historic Short term Debt for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Q3 2023 value amounting to $9.6 million.

  • Orchestra BioMed Holdings' Short term Debt changed N/A to $9.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Short term Debt of $9.6 million as of Q3 2023.
  • In the past 5 years, Orchestra BioMed Holdings' Short term Debt registered a high of $9.6 million during Q3 2023, and its lowest value of $2.1 million during Q4 2022.